INNOSCIENCE (02577) sues Infineon Technologies

INNOSCIENCE (02577) announces that the company and its wholly owned subsidiary, INNOSCIENCE (Suzhou) Semiconductor Co., Ltd. (referred to as "Plaintiffs"), have filed a lawsuit against Infineon Technologies (China) Co., Ltd. (Defendant 1), Infineon Technologies (Wuxi) Co., Ltd. (Defendant 2), and Suzhou Xinwoke Electronic Technology Co., Ltd. (Defendant 3), with the Suzhou Intermediate People's Court of Jiangsu Province, China, regarding patent numbers 202311774650.7 and 202211387983.X ("the Lawsuit"). Plaintiff INNOSCIENCE (Suzhou) is the patent owner of the patents involved, and the company has obtained a license from them. The patents in question involve a gallium nitride (GaN) power device and its manufacturing method, as well as a nitride-based semiconductor device and its manufacturing method. According to the Lawsuit, Defendant 2 is a wholly owned subsidiary of Defendant 1, and is the entity responsible for the registration of Infineon's Chinese website. This website showcases, promotes, and promises to sell various models of gallium nitride (GaN) semiconductor devices (infringing products) to potential customers in China. Defendant 1 is the importer and general distributor of the infringing products, while Defendant 3 is the value-added distributor in China for Defendants 1 and 2. Following a technical comparison, the Plaintiffs believe that the infringing products fall within the protection scope of the patents in question, and the three defendants have engaged in acts of promising to sell, selling, and importing the infringing products without authorization, constituting infringement of the patents in question. They are legally obligated to stop the infringement and take responsibility for compensation. In order to protect its legitimate rights and interests, the Plaintiffs have brought this lawsuit to the court. The company believes that the lawsuit will not have any adverse impact on its normal business operations. The company will continue to seek legal advice actively and take appropriate actions when necessary to safeguard the interests of the company and its shareholders, and minimize any negative impact on the company.